1 Isocitrate dehydrogenase inhibitors in acute myeloid leukemia
来源:BIOMARK RES( P E 2050-7771 ) 发表时间: 2019/10
类型:期刊论文 为本人加分:5818.862234
2 Bone Marrow Fat and Hematopoiesis
来源:FRONT ENDOCRINOL( P 1664-2392 E ) 发表时间: 2018/11
类型:期刊论文 为本人加分:5186.315662
3 Targeting CLL-1 for acute myeloid leukemia therapy
来源:J HEMATOL ONCOL( P E 1756-8722 ) 发表时间: 2019/04
类型:期刊论文 为本人加分:3499.248471
4 Curcumin potentiates the anti-leukemia effects of imatinib by downregulation of the AKT/mTOR pathway..
来源:INT J BIOCHEM CELL B( P 1357-2725 E 1878-5875 ) 发表时间: 2015/08
类型:期刊论文 为本人加分:3029.104178
5 N6-methyladenine RNA modification and cancers
来源:AM J CANCER RES( P 2156-6976 E ) 发表时间: 2018/01
类型:期刊论文 为本人加分:2515.632395
6 Oridonin in combination with imatinib exerts synergetic anti-leukemia effects in Ph+ acute lymphobla..
来源:CANCER BIOL THER( P 1538-4047 E 1555-8576 ) 发表时间: 2012/11
类型:期刊论文 为本人加分:2486.404777
7 Ribavirin Inhibits the Activity of mTOR/eIF4E, ERK/Mnk1/eIF4E Signaling Pathway and Synergizes with ..
来源:PLOS ONE( P 1932-6203 E ) 发表时间: 2015/08
类型:期刊论文 为本人加分:2045.335705
8 High Wilms' tumor 1 associating protein expression predicts poor prognosis in acute myeloid leuk..
来源:J CANCER RES CLIN( P 0171-5216 E 1432-1335 ) 发表时间: 2021/01
类型:期刊论文 为本人加分:1864.674012
贡献度:单独通讯作者
9 The m6A RNA methyltransferase METTL3/METTL14 promotes leukemogenesis through the mdm2/p53 pathway in..
来源:J CANCER( P 1837-9664 E ) 发表时间: 2022/01
类型:期刊论文 为本人加分:1530.471136
贡献度:单独通讯作者
10 Prognostic value of SRSF2 mutations in patients with de novo myelodysplastic syndromes: A meta-analy..
来源:PLOS ONE( P 1932-6203 E ) 发表时间: 2017/09
类型:期刊论文 为本人加分:1526.661271